A process in drug discovery and development where initial "hits" or promising lead compounds are further optimized to improve their potency, selectivity, and pharmacokinetic properties. This iterative process aims to identify potential drug candidates for further preclinical and clinical studies.
If you need to purchase chemical raw materials, submit your demand information to get the latest quotations.
4-(2-hydroxy-3-(1-(5-(thiophen-2-yl)thieno[2,3-d]pyrimidin-4-yl)piperidin-4-ylamino)propoxy)phenol
Diphenylmethyl-dichlormethyl-sulfon
